MediciNova Inc. (MNOV): MNOV moving up?


MediciNova Inc. (NASDAQ:MNOV) changes shares on Monday trading session, with a change of 19.77% or $1.05 shares. The trading starts at $6.16 and closed at $5.31 throughout the day. The trading session low price was $6.06 and day high was $6.39 on Monday, June 15. After the session, the Healthcare sector daily volume shifted to 0.24 million while its average volume is 172.72K. In other hand, the MNOV market cap reached to $276.53M. While, its current target price is $6.36 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 16.27% and up 11.38% for month. Its quarterly performance was 61.83% above, while its half year performance is down -17.72%. MNOV yearly performance stood at negative -31.83% and fall -5.64% for year-to-date. Current recommendation for MediciNova Inc. is 1.50.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. MNOV EPS (TTM) for 12-month is -0.25. EPS for this year is 16.00%, while for the next year its value is -0.43. Its EPS Q/Q reached 44.20%. It has an EPS of 4.70% up for past five years and for the next five years will be up 20.00%.

Let’s take a look on the analyst recommendations on MNOV for the current month and previous month. For the current month, 3 of 3 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $11.00-$24.00. Average target price for MNOV was reached at $18.37.

The insider ownership moved to 2.20% and institutional holding shifted to 22.00%.

The company posted an EPS (TTM) of -0.25. According to the most recent quarter report on (Jun 2020), 3 analysts estimated an average EPS of -0.1, while -0.09 EPS posted a year ago period. Analyst Estimated EPS for MNOV published in the report was -0.15–0.07 during the same period. Comparing with last year, the average estimated EPS was -0.09 which is lower than -0.06 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for MNOV rise 0.59% for period of 200 days. SMA for 50 days was 20.77% which is showing green signal, while SMA-20 was 17.47%. The moving average value for MediciNova Inc. (MNOV) is 5.56 and 5.44 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in MNOV stock. On Mar 13, Matsuda Kazuko, Chief Medical Officer, bought 2,000 trading shares at the cost of $3.62, which valued at 7240.0. On Mar 12, IWAKI YUICHI, President and CEO, bought 20,000 shares at the cost of $3.10, with total shares of 780,683.